Neuraxis, INC (NRXS) · Oct 14, 2026 · Other events

NeurAxis dividend adds routine dilution, no cash payout

Stock dividend declared — ~81,339 common shares at $2.38 per share

NeurAxis declared its quarterly preferred-stock dividend in common shares. The payment avoids cash outflow but adds modest, expected dilution.

NeurAxis is commercializing neuromodulation devices, including IB-Stim and RED, while trying to expand insurance coverage and fund operations during a still-loss-making growth phase.

This is a routine quarterly obligation, not a new strategic signal. The board declared the Series B preferred-stock dividend for the third quarter, payable October 30 to holders of record October 26. 〔0〕 The company has already established that these preferred shares accrue an 8.5% annual cumulative dividend through December 31, 2026, payable in cash or common shares at its discretion.

ItemThird-quarter dividend
SettlementCommon stock
Shares expectedApproximately 81,339
Conversion price$2.38 per share
Record dateOctober 26, 2026
Payment dateOctober 30, 2026

The trade-off is clear: preserved cash, incremental dilution. Paying in shares avoids a cash payment at a company that reported substantial doubt about its ability to continue as a going concern and expects to need working capital through 2026 and beyond. But the issuance adds roughly 81,000 shares to the common-stock base; that is modest relative to the approximately 12.6 million common shares outstanding as of August 6, 2026. 〔1〕

Bottom line: This filing keeps NeurAxis’s existing financing pattern intact: no immediate cash drain, but recurring dilution. It matters for capital structure, not for the underlying device-commercialization story, and the event was already largely expected.

What to watch next

Dividend payment on October 30, 2026

Original filing on SEC EDGAR

NeurAxis dividend adds routine dilution, no cash payout | NRXS Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.